Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
ADA: Lilly offers deeper glimpse into triple-G obesity candidate
Eli Lilly is keenly aware that the one-size-fits-all approach to obesity and diabetes treatment pioneered by early GLP-1s will soon be obsolete.
Fraiser Kansteiner
Jun 6, 2026 3:28pm
ADA: Pfizer pads case for berobenatide in obesity
Jun 6, 2026 9:29am
Carl Sailer on AI, market trends, and strategic planning in biotech
Brought to you by
Syneos Health
Cullinan's new data makes clearest case yet for autoimmune TCEs
Jun 6, 2026 5:15am
Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization
Brought to you by
Guidehouse
Affibody gets izokibep ‘back on track’ after Acelyrin rejection
Jun 5, 2026 10:42am
